- About UsOur Story, Our Team & Support Information
- What We DoAdvocacy to Achieve the End of AIDS
- Advance HIV/SRH Integration
- Advocate for Access to High-Impact Prevention
- Improve Research Conduct
- Product Innovation & Availability
- Promote Effective HIV Prevention Policy
- Strengthen Global Advocacy Networks
- Track and Translate the Field
- Our FocusInterventions to End the Epidemic
- ResourcesPublications, Infographics, Events & More
- MediaInformation & Resources for the Press
- Our BlogPrevention News & Perspective
Status
Completed
Phase
Open Label
III
Principal Investigator(s)
William Miller
Objective
The purpose of this study is to determine the feasibility of a future trial that will assess whether an integrated intervention combining psychosocial counseling and supported referrals for antiretroviral therapy (ART) at any CD4 cell count and substance use treatment for HIV-infected people who inject drugs (PWID) will reduce HIV transmission to HIV-uninfected injection partners, as compared to routine care dictated by national guidelines for HIV-infected PWID.
Last updated June 10, 2022
Prevention Option(s)
PrEP
Treatment
Study Design
Randomized
Open label
Arms and Assigned Interventions
Description
Experimental: Integrated Intervention
Standard of care plus an integrated system of psychosocial counseling and systems navigation for HIV treatment and Substance Use treatment
ARMs
Experimental
Official Code
Related Publications
Trial Sponsors
HPTN, NIDA, NIAID
February 2015
June 2018
Date of Enrollment Completion
June 16, 2017
Enrollment
1 281
18
Years
45
Years
Population
HIV positive
Injecting drug users
Sites
CIPTO
Jakarta
Indonesia
Ukrainian Institute on Public Health Policy
Kiev
Ukraine
Pho Yen Health Center
Pho Yen, Thai Nguyen
Thailand